(18)F-FDG-PET and PET/CT for Evaluating Primary Bone Tumors

Area of Science:

• Oncology
• Radiology
• Nuclear Medicine

Background:

• Imaging is essential for assessing primary bone tumors.
• Positron emission tomography (PET) and computed tomography (CT) are advanced imaging modalities.

Purpose of the Study:

• To highlight the expanding role of 18F-fluorodeoxyglucose PET and PET/CT in bone tumor management.
• To discuss the utility of these imaging techniques in various aspects of patient care.

Main Methods:

• Review of current literature and clinical applications of 18F-fluorodeoxyglucose PET and PET/CT in bone tumors.
• Analysis of the diagnostic and prognostic capabilities of these imaging modalities.

Main Results:

• 18F-fluorodeoxyglucose PET and PET/CT are valuable for grading, staging, and prognostication of bone tumors.
• These techniques assist in evaluating treatment response and detecting recurrent disease.
• They can help differentiate benign from malignant bone disorders.

Conclusions:

• 18F-fluorodeoxyglucose PET and PET/CT play a critical and growing role in the comprehensive evaluation of primary bone tumors.
• These imaging modalities enhance diagnostic accuracy and therapeutic decision-making in oncology.